Apitope Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
M&A
- Investors
-
1
Apitope General Information
Description
Developer of antigen-specific therapeutic peptides designed to develop novel therapeutics that directly target the underlying cause of allergy and autoimmune disease. The company's peptides are focused on the treatment of allergy and autoimmune diseases including multiple sclerosis, Graves' disease, and Uveitis, enabling patients to enjoy a normal quality of life without the risk of secondary infection and further complications.
Contact Information
Website
www.apitope.comCorporate Office
- Agoralaan
- Building A-bis
- 3590 Diepenbeek
- Belgium
Corporate Office
- Agoralaan
- Building A-bis
- 3590 Diepenbeek
- Belgium
Apitope Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 21-Sep-2021 | Completed | Clinical Trials - Phase 2 | |||
| 6. Secondary Transaction - Private | 01-Mar-2021 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC (Series B) | 29-Sep-2015 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 08-Jan-2014 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 21-Dec-2012 | Completed | Pre-Clinical Trials | |||
| 2. Later Stage VC (Series A) | 09-Dec-2009 | $14.9M | $14.9M | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2002 | Completed | Startup |
Apitope Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Category B | ||||||||
| Category B |
Apitope Comparisons
Industry
Financing
Details
Apitope Competitors (75)
One of Apitope’s 75 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Baliopharm | Venture Capital-Backed | Basel, Switzerland | ||||
| CuraVac | Formerly Accelerator/Incubator backed | Rixensart, Belgium | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Agomab Therapeutics | Formerly VC-backed | Antwerp, Belgium |
Apitope Patents
Apitope Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230203126-A1 | A composition comprising s-arrestin peptides | Pending | 23-Dec-2019 | ||
| WO-2021130653-A1 | A composition comprising s-arrestin peptides | Inactive | 23-Dec-2019 | ||
| GB-201919222-D0 | Composition | Inactive | 23-Dec-2019 | ||
| GB-201909774-D0 | Method | Inactive | 08-Jul-2019 | ||
| US-20220260587-A1 | Method | Inactive | 08-Jul-2019 | G01N33/6878 |
Apitope Signals
Apitope Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arix Capital Management | Asset Manager | Minority | ||
| European Commission | Government | |||
| LRM | Venture Capital | Minority | ||
| National Multiple Sclerosis Society (NMSS) | Not-For-Profit Venture Capital | Minority | ||
| PMV (Belgium) | Asset Manager | Minority |
Apitope FAQs
-
When was Apitope founded?
Apitope was founded in 2002.
-
Where is Apitope headquartered?
Apitope is headquartered in Diepenbeek, Belgium.
-
What is the size of Apitope?
Apitope has 1 total employees.
-
What industry is Apitope in?
Apitope’s primary industry is Drug Discovery.
-
Is Apitope a private or public company?
Apitope is a Private company.
-
What is Apitope’s current revenue?
The current revenue for Apitope is .
-
How much funding has Apitope raised over time?
Apitope has raised $28.4M.
-
Who are Apitope’s investors?
Arix Capital Management, European Commission, LRM, National Multiple Sclerosis Society (NMSS), and PMV (Belgium) are 5 of 10 investors who have invested in Apitope.
-
Who are Apitope’s competitors?
AnTolRx, Baliopharm, CuraVac, Inovio Pharmaceuticals, and Agomab Therapeutics are some of the 75 competitors of Apitope.
-
When was Apitope acquired?
Apitope was acquired on 21-Sep-2021.
-
Who acquired Apitope?
Apitope was acquired by Worg.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process